Search clinical trials for: 300mg PF-04950615 (RN316)
Total 24 results
-
PfizerCompletedHypercholesterolemiaUnited States
-
PfizerCompletedHyperlipidemiaUnited States, Canada
-
PfizerCompletedHyperlipidemiaKorea, Republic of, United States, Australia, Germany, Poland, Canada, Italy, Hong Kong, Czech Republic
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States
-
PfizerCompletedMetabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | Hypercholesterolemia | HyperlipidemiasUnited States
-
PfizerCompletedHypercholesterolemiaUnited States
-
PfizerTerminatedCardiovascular DiseaseFinland, United States, Netherlands, Spain, Korea, Republic of, China, Israel, Belgium, Germany, Australia, Czechia, Taiwan, Denmark, United Kingdom, Hungary, Poland, France, Mexico, Turkey, Canada, New Zealand, Colombia, Switzerland, Irelan... and more
-
PfizerCompletedHyperlipidemiaFinland, Netherlands, United States, Canada, Sweden, Korea, Republic of, Singapore, Czechia, Poland, United Kingdom, Puerto Rico, Norway
-
PfizerTerminatedCardiovascular DiseaseUnited States, Finland, Netherlands, Spain, Belgium, Germany, Czechia, Switzerland, Denmark, Australia, United Kingdom, Korea, Republic of, Hungary, Israel, Poland, Taiwan, Mexico, Turkey, Ireland, Canada, New Zealand, South Africa, Brazi... and more
-
PfizerCompletedHyperlipidemiaUnited States, Spain, Taiwan, United Kingdom, Canada, Mexico, France, Hungary, Lithuania, Colombia, Romania, Russian Federation
-
PfizerCompletedHeterozygous Familial HypercholesterolemiaCanada, Netherlands, United Kingdom, United States, Spain, Poland, Finland, Norway, South Africa, Italy, Bulgaria
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada
-
PfizerCompletedHypercholesterolemiaJapan
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada
-
PfizerCompletedHypercholesterolemiaUnited States
-
Kadmon Corporation, LLCCompleted
-
University of California, San FranciscoPfizer; San Francisco General HospitalTerminatedCardiovascular Disease | DyslipidemiaUnited States
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Hungary, Taiwan, Romania, India, South Africa, Philippines, Slovakia
-
PfizerCompleted
-
PfizerCompletedImpotenceNorway, United Kingdom
-
Centre Hospitalier St AnneEtablissement Public de Santé Barthélemy Durand; Groupe Hospitalier Paul GuiraudNot yet recruitingSchizophrenia; PsychosisFrance
-
PfizerCompleted
-
ItalfarmacoCompletedDrug-Drug InteractionPortugal